CEL-SCI Corp. (CVM)
2.74
+0.32
(+13.22%)
USD |
NYAM |
Oct 06, 16:00
2.80
+0.06
(+2.19%)
After-Hours: 05:17
CEL-SCI Price to Book Value : 4.399 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 4.399 |
| October 05, 2026 | 3.885 |
| October 02, 2026 | 3.708 |
| October 01, 2026 | 3.355 |
| September 30, 2026 | 3.307 |
| September 29, 2026 | 2.874 |
| September 28, 2026 | 2.729 |
| September 25, 2026 | 2.681 |
| September 24, 2026 | 2.761 |
| September 23, 2026 | 2.697 |
| September 22, 2026 | 2.729 |
| September 21, 2026 | 2.681 |
| September 18, 2026 | 2.665 |
| September 17, 2026 | 2.392 |
| September 16, 2026 | 2.376 |
| September 15, 2026 | 2.376 |
| September 14, 2026 | 2.440 |
| September 11, 2026 | 2.392 |
| September 10, 2026 | 2.440 |
| September 09, 2026 | 2.472 |
| September 08, 2026 | 2.649 |
| September 04, 2026 | 2.617 |
| September 03, 2026 | 2.585 |
| September 02, 2026 | 2.649 |
| September 01, 2026 | 2.585 |
| Date | Value |
|---|---|
| August 31, 2026 | 2.601 |
| August 28, 2026 | 2.504 |
| August 27, 2026 | 2.569 |
| August 26, 2026 | 2.585 |
| August 25, 2026 | 2.376 |
| August 24, 2026 | 2.216 |
| August 21, 2026 | 2.280 |
| August 20, 2026 | 2.344 |
| August 19, 2026 | 2.633 |
| August 18, 2026 | 2.553 |
| August 17, 2026 | 2.488 |
| August 14, 2026 | 2.472 |
| August 13, 2026 | 2.392 |
| August 12, 2026 | 2.376 |
| August 11, 2026 | 2.440 |
| August 10, 2026 | 2.392 |
| August 07, 2026 | 2.761 |
| August 06, 2026 | 2.585 |
| August 05, 2026 | 2.440 |
| August 04, 2026 | 2.183 |
| August 03, 2026 | 2.007 |
| July 31, 2026 | 1.862 |
| July 30, 2026 | 1.959 |
| July 29, 2026 | 1.830 |
| July 28, 2026 | 1.926 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.62 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.248 |
| Curis, Inc. | 0.3109 |
Price to Book Value Related Metrics
| Price | 2.74 |
| Earnings Yield | -94.26% |
| Market Cap | 48.19M |